Iradimed (IRMD) Shareholder's Equity (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.12% |
| Dec 31, 2025 | -3.80% |
| Sep 30, 2025 | 4.30% |
| Jun 30, 2025 | 4.72% |
| Mar 31, 2025 | 3.73% |
| Dec 31, 2024 | 4.06% |
| Sep 30, 2024 | 4.72% |
| Jun 30, 2024 | 4.66% |
| Mar 31, 2024 | 6.58% |
| Dec 31, 2023 | -4.22% |
| Sep 30, 2023 | 8.07% |
| Jun 30, 2023 | 7.24% |
| Mar 31, 2023 | -12.67% |
| Dec 31, 2022 | 5.59% |
| Sep 30, 2022 | 5.88% |
| Jun 30, 2022 | 5.36% |
| Mar 31, 2022 | -13.34% |
| Dec 31, 2021 | 6.31% |
| Sep 30, 2021 | 4.61% |
| Jun 30, 2021 | 2.89% |
| Mar 31, 2021 | 2.76% |
| Dec 31, 2020 | 1.10% |
| Sep 30, 2020 | 4.03% |
| Jun 30, 2020 | 0.52% |
| Mar 31, 2020 | 4.57% |
| Dec 31, 2019 | 7.25% |
| Sep 30, 2019 | 9.81% |
| Jun 30, 2019 | 5.60% |
| Mar 31, 2019 | 6.44% |
| Dec 31, 2018 | 4.62% |
| Sep 30, 2018 | 77.70% |
| Jun 30, 2018 | 2,124,401.41% |
| Mar 31, 2018 | -100.00% |
| Dec 31, 2017 | 2.46% |
| Sep 30, 2017 | 2.70% |
| Jun 30, 2017 | -2.28% |
| Mar 31, 2017 | 0.43% |
| Dec 31, 2016 | 4.07% |
| Sep 30, 2016 | 7.63% |
| Jun 30, 2016 | -2.65% |
| Mar 31, 2016 | -8.42% |
| Dec 31, 2015 | 13.59% |
| Sep 30, 2015 | 12.06% |
| Jun 30, 2015 | 9.24% |
| Mar 31, 2015 | 9.94% |
| Dec 31, 2014 | 3.67% |
| Sep 30, 2014 | 176.00% |